- Home
- IMMX vs FTHM Comparison
IMMX vs FTHM Comparison
Compare IMMX & FTHM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMX
- FTHM
- Stock Information
- Founded
- IMMX 2014
- FTHM 2010
- Country
- IMMX United States
- FTHM United States
- Employees
- IMMX N/A
- FTHM 241
- Industry
- IMMX Medicinal Chemicals and Botanical Products
- FTHM Real Estate
- Sector
- IMMX Health Care
- FTHM Finance
- Exchange
- IMMX Nasdaq
- FTHM Nasdaq
- Market Cap
- IMMX 61.1M
- FTHM 38.1M
- IPO Year
- IMMX 2021
- FTHM 2020
- Fundamental
- Price
- IMMX $2.10
- FTHM $1.55
- Analyst Decision
- IMMX Strong Buy
- FTHM Strong Buy
- Analyst Count
- IMMX 1
- FTHM 4
- Target Price
- IMMX $7.00
- FTHM $4.25
- AVG Volume (30 Days)
- IMMX 247.3K
- FTHM 76.1K
- Earning Date
- IMMX 11-12-2024
- FTHM 11-07-2024
- Dividend Yield
- IMMX N/A
- FTHM N/A
- EPS Growth
- IMMX N/A
- FTHM N/A
- EPS
- IMMX N/A
- FTHM N/A
- Revenue
- IMMX N/A
- FTHM $317,515,000.00
- Revenue This Year
- IMMX N/A
- FTHM N/A
- Revenue Next Year
- IMMX $200.00
- FTHM $29.09
- P/E Ratio
- IMMX N/A
- FTHM N/A
- Revenue Growth
- IMMX N/A
- FTHM N/A
- 52 Week Low
- IMMX $1.26
- FTHM $1.32
- 52 Week High
- IMMX $7.10
- FTHM $4.33
- Technical
- Relative Strength Index (RSI)
- IMMX 50.86
- FTHM 31.83
- Support Level
- IMMX $2.04
- FTHM $1.42
- Resistance Level
- IMMX $2.44
- FTHM $2.06
- Average True Range (ATR)
- IMMX 0.31
- FTHM 0.15
- MACD
- IMMX -0.03
- FTHM -0.03
- Stochastic Oscillator
- IMMX 26.51
- FTHM 20.31
About IMMX Immix Biopharma Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.
About FTHM Fathom Holdings Inc.
Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, insurance, and Software as a Service offering to brokerages and agents by leveraging proprietary cloud-based software, intelliAgent. The company has three reportable segments namely Real Estate Brokerage, Mortgage and Technology. The brands of the company include Fathom Realty, Dagley Insurance, Encompass Lending, intelliAgent, LiveBy, Real Results, and Verus Title.